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syndrome (RDS). Her mother had gestational diabetes 
mellitus (GDM), but no other pathological disorder was 
found. After delivery, the baby was intubated in a moder-
ately serious condition. Her laboratory results demon-
strated a low white blood cell count, a moderately elevated 
haematocrit and elevated procalcitonin levels. Physical 
examination revealed diffuse respiratory sounds and acro-
cyanosis of the limbs. On the basis of these fi ndings, intra-
uterine infection was suspected, and mechanical ventilation 
and parenteral empirical antibiotic therapy were started. 
On day 4 of extrauterine life, her condition deteriorated 
rapidly because of bleeding from the lungs. After improve-
ment, on day 7, she was extubated, and enteral and partial 
parenteral nourishment was initiated. Blood cultures incu-
bated in the Bactec 9240 Automated Blood Culture System 
(Becton Dickinson, Franklin Lakes, NJ, USA) were posi-
tive for methicillin-resistant  Staphylococcus epidermidis , 
and teicoplanin therapy was therefore commenced. After 
a week, her condition deteriorated again with jaundice and 
tetraplegia occurring on day 14, and on day 15 cultures 
inoculated with blood samples became positive for fungi 
after 15.5 h of incubation. Microbiological investigation 
revealed the presence of slow-growing yeast colonies on 
Sabouraud glucose agar (SGA) plates. The isolate was at 
this stage unidentifi ed and its  in vitro minimal inhibitory 
concentrations (MICs) for fl uconazole, voriconazole and 
amphotericin B were 2, 0.032, and 0.004 mg/l, respectively 
[8]. Fluconazole therapy (6 mg/kg/d) was carried out for 
three days after the isolate was interpreted as susceptible. 
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 Although neonatal bloodstream infections may be caused by a variety of fungi, invasive 
fungaemia due to  Candida pulcherrima in a premature neonate has not been previously 
reported. We describe such a case in which antifungal susceptibility test data led to 
 successful therapy. A colonized catheter used for parenteral nutrition is presumed to 
have been the main source of this persistent infection. 
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 Introduction 
Statistical data from different reports point to a gradual 
increase in the number of cases of fungal infections per 
year, including the presence of different or rare yeasts and 
fi lamentous fungi being recovered from clinical specimens 
[1]. The rates of morbidity and mortality of fungal blood-
stream infections are signifi cant in immunocompromised 
patients.  Candida pulcherrima is occasionally able to cause 
life-threatening infections [2 – 7] and seems to be one of the 
opportunistic non- C.  albicans  Candida species which can 
colonize some parts of the human body. Invasive candidi-
asis in neonates is a severe and relatively common cause 
of sepsis associated with high mortality. The increasing 
number of non- C.  albicans yeast infections emphasizes the 
need for the accurate identifi cation of rare yeasts in routine 
diagnostics for adequate therapy. 
 Case report 
A premature newborn Caucasian girl born as a gemini B 
twin in the 36th week of gestation, with a birth weight of 
2,840 g, was admitted to the Neonatal Intensive Care Unit 
at the University of Szeged with severe respiratory distress 
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On day 21, blood culture positivity reappeared for the same 
yeast (after 20 h of incubation), and the same MIC results 
were found. To overcome the suspected  in vivo lower 
 susceptibility or resistance to fl uconazole, amphotericin B 
lipid complex therapy (5 mg/kg/d) was initiated. After 
6 days, her general condition had improved, but abdominal 
ultrasound imaging revealed the development of a hepatic 
abscess. After 15 days of amphotericin B therapy, the blood 
cultures became negative (on day 33), and after a few days 
the hepatic abscess was observed to be smaller on ultra-
sound examination. With regard to her improving general 
condition, the girl was discharged from the hospital. The 
MIC values determined by Etest (bioM é rieux, Marcy 
l ’ Etoile, France) on four occasions during the infection 
(days 15, 20, 25 and 29), showed the same results, i.e., 
fl uconazole  – 2 mg/l; voriconazole  – 0.032 mg/l; and 
amphotericin B  – 0.004 mg/l [8]. 
 Microbiology 
The colonies on SGA were slow-growing, convex and 
cream-coloured, with smooth surfaces and entire margins. 
Growth was adequate at 25 – 30 ° C but insuffi cient at 37 ° C 
on every agar medium. The micromorphology on Difco 
rice starch agar (RSA; Becton Dickinson) revealed ovoid 
vegetative cells (4 – 6  μ m) without pseudohyphal growth 
with faint droplets of oil after 24 h at 25 ° C. On CHROMagar 
Candida (Becton Dickinson), pale-purple, waxy colonies 
were formed, as found with many other yeasts. After 48 h 
under the same conditions, the micromorphology on RSA 
demonstrated numerous subspherical chlamydospores with 
a relatively large cell size (7 – 10  μ m), thick cell walls and 
large drops of oil. After 1 week, no considerable changes 
in micromorphology were detected as compared with the 
cultures after 48 h (Fig. 1). The macromorphology of 
 colonies on SGA exhibited characteristic features after 
48 h, i.e., a faint halo of diffusible wine-red pigment (pul-
cherrimin) on the reverse side of larger isolated colonies. 
After 1 week at 25 ° C, the red halo expanded beyond the 
colony and extended to some millimetres.
The biochemical pattern of the isolate was determined 
with an AUXACOLOR 2 (Bio-Rad, Hercules, CA, USA) 
assimilation kit and additional tests. Assimilation studies 
at 30 ° C revealed that after 48 h the isolate was positive for 
glucose, maltose, sucrose, galactose, cellobiose, trehalose, 
adonitol, melezitose and xylose and negative for lactose, 
raffi nose, inositol, hexosaminidase, phenoloxidase, proline-
arylaminidase, arabinose, nitrate and urease.
Molecular characterization was carried out by sequenc-
ing a fragment of internal transcribed spacer (ITS) region 
amplicon (18S, 5.8S and 26S rDNA), the primers were 
ITS1 (5 ′ -TCCGTAGGTGAACCTGCG-3 ′ ) and ITS4 
(5 ′ -TCCTCCGCTTATTGATATGC-3 ′ ) [9]. Blast analysis 
in GenBank indicated a nearly complete sequence align-
ment with  Metschnikowia pulcherrima strains (with 99% 
identity). The production of pulcherrimin and examina-
tions on diluted V8 juice agar [10] revealing the lack of 
ascospore production indicated the asexual anamorphic 
stage of the isolate, and it was therefore identifi ed as 
 C. pulcherrima . The results of sequencing (358 bp) of the 
ITS region of the isolated  C. pulcherrima strain have 
been deposited under the accession number JN229413 in 
GenBank. 
 Discussion 
 Candida pulcherrima , a common environmental yeast, is 
a rare opportunistic pathogen in humans. The species is the 
anamorphic stage of the ascosporic fungus  M.  pulcher-
rima , a non-pathogenic member of the surface fl ora of 
some fruits, and especially noble rotting botrytized grapes. 
 Candida pulcherrima is a member of the oral cavity fl ora 
in adults, but veterinary isolations have also been reported. 
Most of the human pathogenic reports involved onycho-
mycosis, root caries lesions, respiratory diseases and a few 
cases of bloodstream infections [2 – 7].
In our case, numerous risk factors for invasive fungal 
infection were present simultaneously, i.e., a premature 
newborn patient, GDM of the mother, a parenteral medical 
device, basic RDS and prophylactic antibiotic therapy. It is 
important to emphasize the  in vivo ineffectiveness of fl u-
conazole in the treatment of the patient. The  in vivo and in 
vitro fi ndings from  in vitro susceptibility tests were com-
pletely different because of the long-lasting fungal pres-
ence in the bloodstream. Only limited data are available in 
the literature but they indicate that  C. pulcherrima is sus-
ceptible  in vitro to fl uconazole, voriconazole and anidula-
fungin [11,12]. Neither intrinsic resistance, nor lowered 
 Fig. 1 Micromorphology of  Candida pulcherrima isolate on RSA at 48 h. 
Chlamydospores were formed among the crowd of budding cells. No 
pseudohyphal growth was seen. Magnifi cation   400; bar denotes 20  μ m. 
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susceptibility to any antimycotic is known for this species. 
It is also necessary to emphasize the importance of the 
colonization of medical devices such as parenteral nutri-
tional catheters, as demonstrated in similar cases where, 
besides the fl uconazole treatment of a  C. pulcherrima blood-
stream infection, removal of a biofi lm-colonized parenteral 
catheter was a key step in the successful therapy [3,7].
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